Ringbaek Thomas, Brøndum Eva, Martinez Gerd, Lange Peter
Pulmonary Rehabilitation Research Group, Department of Cardiology and Respiratory Medicine, University Hospital of Copenhagen, Hvidovre, Denmark.
Respir Med. 2008 Nov;102(11):1563-7. doi: 10.1016/j.rmed.2008.06.016. Epub 2008 Aug 9.
The effect of pulmonary rehabilitation on EuroQol in COPD patients has not been investigated previously.
METHODS/MATERIALS: Two hundred and twenty nine consecutive COPD patients who had completed a 7-week pulmonary rehabilitation programme were assessed with EuroQol five-dimension questionnaire (EQ-5D), endurance shuttle walk test (ESWT), and the St George's Respiratory Questionnaire (SGRQ) before and after the programme, and at the 3-month follow-up visit.
Two hundred and two (88.4%) patients had FEV(1)<50% predicted and all but four (1.7%) had dyspnoea score at least 3 on MRC scale. At completion of the programme, statistical significant improvements were seen for ESWT 157.3s; p<0.001, EQ-5D utility score -0.019; p=0.03, EQ-5D VAS -2.1; p=0.056, SGRQ total score -2.8 units; p<0.001. The effects of rehabilitation on ESWT and SGRQ were maintained at 3-month follow-up (158.9s and -2.9 units), while the effect on EQ-5 utility decreased (0.013; p=0.18). At baseline, there was a maximum score ("ceiling effect") for EQ-5D utility and EQ VAS in 29 (12.7%) and five (2.2%) of the patients, respectively. After rehabilitation these number increased to 41 (17.9%) and seven (3.1%).
In COPD patients receiving rehabilitation, responsiveness of EQ-5D utility was poor. One explanation might be a "ceiling effect" of this instrument.
此前尚未研究过肺康复对慢性阻塞性肺疾病(COPD)患者欧洲五维健康量表(EuroQol)的影响。
方法/材料:对229例连续完成7周肺康复计划的COPD患者,在计划前后及3个月随访时,采用欧洲五维健康量表问卷(EQ-5D)、耐力穿梭步行试验(ESWT)和圣乔治呼吸问卷(SGRQ)进行评估。
202例(88.4%)患者的第1秒用力呼气容积(FEV₁)<预计值的50%,除4例(1.7%)外,所有患者的改良英国医学研究委员会(MRC)呼吸困难量表评分至少为3分。在计划完成时,ESWT有显著改善,增加157.3秒;p<0.001,EQ-5D效用评分增加-0.019;p=0.03,EQ-5D视觉模拟量表(VAS)增加-2.1;p=0.056,SGRQ总分降低2.8分;p<0.001。康复对ESWT和SGRQ的影响在3个月随访时得以维持(分别为158.9秒和降低2.9分),而对EQ-5效用的影响有所下降(0.013;p=0.18)。在基线时,分别有29例(12.7%)和5例(2.2%)患者的EQ-5D效用和EQ VAS达到最高分(“天花板效应”)。康复后,这一数字分别增至41例(17.9%)和7例(3.1%)。
在接受康复治疗的COPD患者中,EQ-5D效用的反应性较差。一种解释可能是该工具存在“天花板效应”。